---
title: "Top 10 HK Stock Gainers (10.31)"
description: "PEGBIO CO-B(02565) rose 16.02%, with a trading turnover 33.0 Million HKD, and a year-to-date rose 285.3%. DEEPEXI TECH(01384) rose 15.02%, with a trading turnover 610.9 Million HKD, and a year-to-date"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/263687445.md"
published_at: "2025-10-31T08:31:11.000Z"
---

# Top 10 HK Stock Gainers (10.31)

> PEGBIO CO-B(02565) rose 16.02%, with a trading turnover 33.0 Million HKD, and a year-to-date rose 285.3%. DEEPEXI TECH(01384) rose 15.02%, with a trading turnover 610.9 Million HKD, and a year-to-date rose 326.5%. CHUNLI MEDICAL(01858) rose 14.04%, with a trading turnover 395.6 Million HKD, and a year-to-date rose 123.1%.

Hang Seng Index has fell 1.43%, with a year-to-date rose 29.1%; Hang Seng TECH Index has fell 2.37%, with a year-to-date rose 32.2%.

PEGBIO CO-B(02565) rose 16.02%, with a trading turnover 33.0 Million HKD, and a year-to-date rose 285.3%.

DEEPEXI TECH(01384) rose 15.02%, with a trading turnover 610.9 Million HKD, and a year-to-date rose 326.5%.

CHUNLI MEDICAL(01858) rose 14.04%, with a trading turnover 395.6 Million HKD, and a year-to-date rose 123.1%.

### Related Stocks

- [02565.HK - PEGBIO CO-B](https://longbridge.com/en/quote/02565.HK.md)
- [01384.HK - DEEPEXI TECH](https://longbridge.com/en/quote/01384.HK.md)
- [01858.HK - CHUNLI MEDICAL](https://longbridge.com/en/quote/01858.HK.md)
- [01530.HK - 3SBIO](https://longbridge.com/en/quote/01530.HK.md)
- [09606.HK - DUALITYBIO-B](https://longbridge.com/en/quote/09606.HK.md)
- [01541.HK - IMMUNEONCO-B](https://longbridge.com/en/quote/01541.HK.md)
- [02315.HK - BIOCYTOGEN-B](https://longbridge.com/en/quote/02315.HK.md)
- [01860.HK - MOBVISTA](https://longbridge.com/en/quote/01860.HK.md)
- [01801.HK - INNOVENT BIO](https://longbridge.com/en/quote/01801.HK.md)
- [09676.HK - SHIYUE DAOTIAN](https://longbridge.com/en/quote/09676.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Biocytogen Sets Out Board Structure and Committee Roles | Biocytogen Pharmaceuticals (Beijing) Co. Ltd. has announced its board structure, led by Chairman and CEO Dr. Shen Yuelei | [Link](https://longbridge.com/en/news/275756980.md) |
| Nomura Adjusts Innovent Biologics' Price Target to HK$114.64 From HK$105.08, Keeps at Buy | Nomura Adjusts Innovent Biologics' Price Target to HK$114.64 From HK$105.08, Keeps at Buy | [Link](https://longbridge.com/en/news/275882948.md) |
| Shiyue Daotian Group Files Next Day Disclosure to HKEX for Repurchase of 486,900 Shares at HKD 4.25 Million | Shiyue Daotian Group Co. Ltd. has disclosed to the Hong Kong Stock Exchange the repurchase of 486,900 shares for a total | [Link](https://longbridge.com/en/news/275584688.md) |
| Shiyue Daotian Group Files HKEX Disclosure on Repurchase of 450,000 Shares for HKD 4.03 Million | Shiyue Daotian Group Co. Ltd. has disclosed to the Hong Kong Stock Exchange the repurchase of 450,000 shares for a total | [Link](https://longbridge.com/en/news/275438989.md) |
| Shiyue Daotian Repurchases 900,000 Shares for HKD 8.3 Million in HKEX Filing | Shiyue Daotian Group Co. Ltd. has announced the repurchase of 900,000 shares for a total of HKD 8.3 million, as disclose | [Link](https://longbridge.com/en/news/275300240.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.